A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles.
Citations
24 citations
Cites methods from "A Next Generation Connectivity Map:..."
...Abbreviations AhR Aryl hydrocarbon receptor AOP Adverse outcome pathway AR Androgen receptor ATP Adenosine triphosphate BMI Body mass index BPA Bisphenol A CAR Constitutive androstane receptor DDT Dichlorodiphenyltrichloroethane DEHP Bis(2-ethylhexyl) phthalate ED Endocrine disruptor ER Estrogen receptor ERR Estrogen-related receptor FXR Farnesoid X receptor GR Glucocorticoid receptor H2020 Horizon 2020 framework programme HTVS High throughput virtual screening INMA INfancia y Medio Ambiente (Environment and Childhood project) KE Key event KuBiCo Kuopio Birth Cohort LINCS Library of Integrated Network-Based Cellular Signatures LXR Liver X receptor MARCoNI Microarray Assay for Real-time Coregulator-Nuclear receptor Interaction MDC Metabolism disrupting chemical MIE Molecular initiating event MISA Miljøgifter i Svangerskapet og i Ammeperioden (Northern Norway Mother-and-Child contaminant Cohort study) MM_GBSA Molecular mechanics/Generalized Born Surface Area MMP Mitochondrial membrane potential NAFLD Non-alcoholic fatty liver disease NFBC The Northern Finland Birth Cohort NMR Nuclear magnetic resonance NR Nuclear receptor OECD Organisation for Economic Co-operation and Development PBDE Polybrominated diphenyl ether PCB Polychlorinated biphenyl PFOS Perfluorooctanesulfonic acid POP Persistent organic pollutants PPAR Peroxisome proliferator-activated receptor QSAR Quantitative structure-activity relationship RXR Retinoid X receptor T2D Type II diabetes TR Thyroid hormone receptor VDR Vitamin D receptor WHO World Health Organization...
[...]
...Specifically, DrugMatrix [54], Open TG-GATEs [55], and the Library of Integrated Network-based Cellular Signatures L1000 dataset (LINCS) [56] will be used for the identification of putative molecular mechanisms linking ED MIEs to adverse outcomes....
[...]
24 citations
Cites methods from "A Next Generation Connectivity Map:..."
...For example, the Connectivity Map [91] contains 1 million profiles of cell liens treated with different drugs and has been successfully used for drug repurposing using network analysis [92]....
[...]
...Subramanian A, Narayan R, Corsello SM, Peck DD, Natoli TE, Lu X, Gould J, Davis JF, Tubelli AA, Asiedu JK, et al. A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles....
[...]
24 citations
24 citations
23 citations
Cites background from "A Next Generation Connectivity Map:..."
..., 2006) and the Library of Integrated Network-based Cellular Signatures (LINCS; Subramanian et al., 2017; Keenan et al., 2018; Koleti et al., 2018)....
[...]
...If the transcriptional signature of drug C is inversely correlated to that of disease Y and/or positively correlated to that of drug D, which has been used to treat disease Y, it is likely that drug C may be used to treat disease Y. Representative resources for this approach are the Connectivity Map (Lamb et al., 2006) and the Library of Integrated Network-based Cellular Signatures (LINCS; Subramanian et al., 2017; Keenan et al., 2018; Koleti et al., 2018)....
[...]
References
34,830 citations
30,124 citations
10,968 citations
8,326 citations
6,319 citations